157 related articles for article (PubMed ID: 34887712)
1. Radiomic Features of
Zhou Y; Zhu Y; Chen Z; Li J; Sang S; Deng S
Contrast Media Mol Imaging; 2021; 2021():6347404. PubMed ID: 34887712
[TBL] [Abstract][Full Text] [Related]
2. Intratumor Heterogeneity Assessed by
Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
Acad Radiol; 2020 Aug; 27(8):e183-e192. PubMed ID: 31761665
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Pretreatment Radiomic Features of 18F-FDG PET in Patients With Hodgkin Lymphoma.
Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
Clin Nucl Med; 2019 Oct; 44(10):e559-e565. PubMed ID: 31306204
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic evaluation value of (18)F-FDG PET-CT in Hodgkin's lymphoma after treatment].
Wan H; Liu P; Liang Y; Jiang SY; Lyu L; Zhang ZW; Wu N; Liu Y
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1275-1281. PubMed ID: 34915636
[No Abstract] [Full Text] [Related]
5. Prediction of Overall Survival and Progression-Free Survival by the
Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
[No Abstract] [Full Text] [Related]
6. Prognostic Value of Baseline Radiomic Features of
Lue KH; Wu YF; Lin HH; Hsieh TC; Liu SH; Chan SC; Chen YH
Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33379166
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an
Wang H; Zhao S; Li L; Tian R
Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
[TBL] [Abstract][Full Text] [Related]
8. Baseline
Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
[TBL] [Abstract][Full Text] [Related]
9. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Radiomic Features of
Zhou Y; Li J; Zhang X; Jia T; Zhang B; Dai N; Sang S; Deng S
Front Oncol; 2022; 12():834288. PubMed ID: 35198451
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
12. Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.
Abenavoli EM; Linguanti F; Anichini M; Miele V; Mungai F; Palazzo M; Nassi L; Puccini B; Romano I; Sordi B; Sciagrà R; Simontacchi G; Vannucchi AM; Berti V
Hematol Oncol; 2024 Mar; 42(2):e3261. PubMed ID: 38454623
[TBL] [Abstract][Full Text] [Related]
13. Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [
Nakajo M; Jinguji M; Tani A; Kikuno H; Hirahara D; Togami S; Kobayashi H; Yoshiura T
Mol Imaging Biol; 2021 Oct; 23(5):756-765. PubMed ID: 33763816
[TBL] [Abstract][Full Text] [Related]
14. CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.
Ganeshan B; Miles KA; Babikir S; Shortman R; Afaq A; Ardeshna KM; Groves AM; Kayani I
Eur Radiol; 2017 Mar; 27(3):1012-1020. PubMed ID: 27380902
[TBL] [Abstract][Full Text] [Related]
15. Value of
Hu Y; Zhao X; Zhang J; Han J; Dai M
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):231-240. PubMed ID: 32588088
[TBL] [Abstract][Full Text] [Related]
16. Pre-Therapeutic Total Lesion Glycolysis on [
Mayerhoefer ME; Staudenherz A; Kiesewetter B; Weber M; Simonitsch-Klupp I; Gibbs P; Dolak W; Lukas J; Raderer M
Mol Imaging Biol; 2019 Dec; 21(6):1192-1199. PubMed ID: 30847823
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
Wu LL; Liang JH; Wang L; Xu W; Ding CY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
[No Abstract] [Full Text] [Related]
18. Can pretreatment
Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
[TBL] [Abstract][Full Text] [Related]
19. Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
Jia T; Lv Q; Cai X; Ge S; Sang S; Zhang B; Yu C; Deng S
Front Oncol; 2023; 13():1210125. PubMed ID: 37576897
[TBL] [Abstract][Full Text] [Related]
20. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
[Next] [New Search]